Sinclair Pharma (SPH)
SPH Share PerformanceMore
|52 week high||40.000 05/02/16|
|52 week low||26.000 28/09/16|
|52 week change||-5.750 (-14.74%)|
|4 week volume||9,269,689 27/12/16|
Latest News« previous» nextMore
17/01/2017 - 09:27 RNS
RNS Number: 3509U Sinclair Pharma PLC 17 January 2017 Hardman Research: Demanding targets exceeded Demanding targets exceeded - Sinclair is a pure-play aesthetics company with a concentrated and highly competitive portfolio of differentiated injectable aesthetics products, which target unmet clinical needs for effective, high quality, longer duration, natura...
17/01/2017 - 07:35 StockMarketWire
Sinclair Pharma is pleased with its 2016 performance, a year when it made excellent progress in its strategy to build a leadi...
17/01/2017 - 07:00 RNS
RNS Number: 2924U Sinclair Pharma PLC 17 January 2017 Pre-Close Trading Update 37.8 million 12 month revenue to December 31 2016, growth of 51%* Strong performance of all brands Successful US launch of Silhouette Instalift London, 17 January 2017 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics company, announce...
05/01/2017 - 07:15 RNS
Notification of the date financial results will be published
11/11/2016 - 16:58 Interactive Investor
Lots of AIM companies could be affected by Donald Trump's likely policies. Former AIM writer of the year Andrew Hore...
08/11/2016 - 09:08 RNS
08/11/2016 - 07:05 RNS
18/10/2016 - 16:55 RNS
Notification of major interests in shares
|Dividend yield||0 %|
Equity Research (SPH)
Sinclair Pharma plc
Sinclair has evolved into a pure-play aesthetics company with a concentrated and highly competitive portfolio of differentiated injectable aesthetics products. These products target unmet clinical...
Latest discussion posts More
“Already an Acquisition Nestle Health Science on Feb. 2 said it acquired CM&D Pharma Ltd., a small U.K. company that develops foods for special medical purposes, primarily ...”▼
“Nestle seems determined to take on its rivals in the dermatology field. A few days ago, Nestle enrolled Allergan executive Paul Navarre, (president of Allergan?s international ...”▼
“..... and the recent currency movement can surely only help. E”▼
Codes & Symbols
|Symbols||SPH, LSE:SPH, SPH.L, SPH:LN, LON:SPH, XLON:SPH|